Ovarian Cancer
Vision - Eliminate ovarian cancer
» Click on Image to View Program Booklet
» Click on Image to View Research Update
Ovarian cancer is the leading cause of death among gynecological cancers each year. In 2016, approximately 22,280 women will be diagnosed with ovarian cancer in the United States, and an estimated 14,240 will die from the disease. About 5% of cancer deaths among women are attributed to ovarian cancer.
The Department of Defense (DoD) Ovarian Cancer Research Program (OCRP) supports high-impact, cutting-edge research that fills unmet needs. The OCRP establishes priorities to target the most critical needs along the pipeline from basic to translational to clinical research and to push the field of ovarian cancer forward in our vision to eliminate this disease. Our current research priorities include:
- Understanding the precursor lesion/stem cell, microenvironment, and pathogenesis/progression of all types of ovarian cancer including rare subtypes
- Developing or improving performance and reliability of screening, diagnostic approaches, and treatment
- Developing and validating models to study initiation and progression of ovarian cancer
- Addressing issues in primary prevention and survivorship
- Investigating tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, and tumor heterogeneity
- Enhancing pool of ovarian cancer scientists
Do You Know Ovarian Cancer Facts & Statistics?
Congressional Appropriations
- $256.5 million
FY97-FY15 - $20.0 million
FY16
Funding
Summary
- 346 Awards in FY97-14
- Recent Applications Recommended for Funding
Programmatic
Panels
Peer Review Participants
Ovarian Cancer Academy
Inspiring a New Generation of Ovarian Cancer Researchers
News & Highlights
- Providing Hope: Increasing Long-Term Survivorship of Ovarian Cancer Patients
- Genetic Modifiers of Ovarian Cancer Risk in BRCA1 Mutation Carriers
- Optical Imaging Falloposcope for Minimally Invasive Ovarian Cancer Detection
- Annie Ellis: Sisterhood and Service
- Ubiquitin-Mediated Protein Degradation Pathways for Ovarian Cancer Treatment
- Repurposing FDA-Approved Drug as a Potential Metastasis Inhibitor for Ovarian Cancer Treatment
- More…
Vision
Eliminate ovarian cancer
Mission
To support patient-centered research to prevent, detect, treat, and cure ovarian cancer
Last updated Friday October 14 2016